Page 14 - SLIDES
P. 14

AURA Conclusions






                • High pathologic complete responses








                • Managable toxicity profile; postop complication data is


                   pending








                • No differences across groups








                • Results in cis-ineligible patients needed
   9   10   11   12   13   14   15   16   17   18   19